Top compounds associated with response to MYO1D

Feature Type	Compound	Dataset	Tissue	Stat	Standardized Coefficient	Nominal ANOVA p-value
mRNA	Gefitinib	GDSC1000	pan-cancer	AAC	0.11	0.003
mRNA	IPA-3	GDSC1000	pan-cancer	AAC	-0.11	0.003
mRNA	Dasatinib	CTRPv2	pan-cancer	AAC	-0.12	0.003
mRNA	selumetinib:navitoclax (8:1 mol/mol)	CTRPv2	pan-cancer	AAC	0.12	0.003
mRNA	thapsigargin	GDSC1000	pan-cancer	AAC	-0.11	0.003
mRNA	GSK429286A	GDSC1000	pan-cancer	AAC	-0.11	0.003
mRNA	BRD-K90370028	CTRPv2	pan-cancer	AAC	0.17	0.004
mRNA	RDEA119	GDSC1000	pan-cancer	AAC	0.098	0.004
mRNA	erastin	CTRPv2	pan-cancer	AAC	-0.11	0.004
mRNA	selumetinib:PLX-4032 (8:1 mol/mol)	CTRPv2	pan-cancer	AAC	0.11	0.005

Download CSV